implanon implantat
2care4 aps - etonogestrel - implantat
nexplanon 68 mg implantat
n.v. organon - etonogestrel - implantat - 68 mg
prograf 1 mg kapsler, hårde
astellas pharma a/s - tacrolimus (vandfrit) - kapsler, hårde - 1 mg
prograf 5 mg kapsler, hårde
astellas pharma a/s - tacrolimus (vandfrit) - kapsler, hårde - 5 mg
zeldox 10 mg/ml oral suspension
upjohn eesv - ziprasidonhydrochlorid - oral suspension - 10 mg/ml
smartgrass vandopløseligt granulat
sumitomo chemical agro europe s.a. - gibberellinsyre - vandopløseligt granulat - 400 g/kg gibberellinsyre a3
entargo suspensionskoncentrat
basf a/s - boscalid - suspensionskoncentrat - 500 g/l boscalid
nexplanon 68 mg implantat
paranova danmark a/s - etonogestrel - implantat - 68 mg
pylclari
curium pet france - piflufolastat (18f) - prostatiske neoplasmer - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).